The introduction of United States Pharmacopoeia (USP) <232>and International Conference on Harmonisation (ICH) Q3D has required the pharmaceutical industry to re-evaluate how elemental impurity (heavy metal) is performed.

USP <735>and European Pharmacopoeia (EP) 2.2.37 enable the use of X-ray fluorescence (XRF) spectrometry for this analysis.

In this webinar, the capabilities of the Malvern Panalytical’s new benchtop XRF system Epsilon 4 to analyse elemental impurities according to USP <232>and ICH Q3D will be demonstrated.

This webinar will take place on 17 october at 10:30 (GMT-5:00) to 11:30.

Register today.